bsm-51629M [Primary Antibody]
Fragilis Monoclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Mouse

Target Protein: Fragilis

Immunogen Range: 21-133/133


Clonality: Monoclonal

Entrez Gene: 10410

Swiss Prot: Q01628

Source: KLH conjugated synthetic peptide derived from human Fragilis

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Background:

IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus (WNV), by inhibiting the early step(s) of replication.

Size: 100ul

Concentration: 0.5ug/ul

Applications: WB=1:500-2000，

Predicted Molecular Weight: 15


Predicted Cross Reactive Species: Human

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Yongtao Zhang. et al. The novel role of IFITM1C3 in myogenic differentiation of C2C12 cells. INTRACTABLE RARE DIS. 2023 Aug 18Read more>>
VALIDATION IMAGES

Lane 1: NCI-H460 cell lysates; Lane 2: HepG2 cell lysates probed with Fragilis Monoclonal Antibody, Unconjugated (bsm-51629M) at 1:4000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.